Exelixis (EXEL) PT Raised to $41 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EXEL Hot Sheet
Price: $72.31 +3.11%
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 22 | New: 15
Rating Summary:
14 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 22 | New: 15
Join SI Premium – FREE
Barclays analyst Etzer Darout raised the price target on Exelixis (NASDAQ: EXEL) to $41.00 (from $40.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Exelixis (EXEL) PT Raised to $78 at H.C. Wainwright
- Exelixis (EXEL) PT Raised to $60 at Morgan Stanley
- UBS Downgrades Alphatec Holdings (ATEC) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
